AGP Picks
View all

Healthy Living Europe
Provided by AGP

Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

October 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on October 19, 2026

The Zoldonat Injection Market Outlook Improves as Global Demand Increases
Oct. 19, 2026

The Zoldonat Injection Market Outlook Improves as Global Demand Increases

Indeterminate EIN Presswire
Viaffinity Unveils Via, Its Next Generation Platform for Embedded Insurance
Oct. 19, 2026

Viaffinity Unveils Via, Its Next Generation Platform for Embedded Insurance

Indeterminate EIN Presswire
Remote Heart Monitoring at KFSH Reduces Heart Failure Admissions by 46%
Oct. 19, 2026

Remote Heart Monitoring at KFSH Reduces Heart Failure Admissions by 46%

Indeterminate GlobeNewswire
KFSH Cuts Emergency Department Boarding Time by 75% Through AI-Enabled Patient Flow System
Oct. 19, 2026

KFSH Cuts Emergency Department Boarding Time by 75% Through AI-Enabled Patient Flow System

Indeterminate GlobeNewswire
XBiotech gibt positive endgültige Wirksamkeitsergebnisse der Phase-II-Studie „TASKIN“ bekannt, einer von Forschern initiierten Studie zur Behandlung von refraktärem metastasiertem Kolorektalkarzinom
Oct. 19, 2026

XBiotech gibt positive endgültige Wirksamkeitsergebnisse der Phase-II-Studie „TASKIN“ bekannt, einer von Forschern initiierten Studie zur Behandlung von refraktärem metastasiertem Kolorektalkarzinom

Indeterminate GlobeNewswire
XBiotech annonce des résultats d’efficacité finaux positifs de phase II pour l’essai TASKIN commandité par un chercheur dans le cancer colorectal métastatique réfractaire
Oct. 19, 2026

XBiotech annonce des résultats d’efficacité finaux positifs de phase II pour l’essai TASKIN commandité par un chercheur dans le cancer colorectal métastatique réfractaire

Indeterminate GlobeNewswire
Pharmacore secures funding to improve medication regimen reviews in long-term care
Oct. 19, 2026

Pharmacore secures funding to improve medication regimen reviews in long-term care

Indeterminate GlobeNewswire
Top Modified Citrus Pectin Manufacturer Zhejiang Gold Kropn Advances Functional Ingredient Innovation
Oct. 19, 2026

Top Modified Citrus Pectin Manufacturer Zhejiang Gold Kropn Advances Functional Ingredient Innovation

Indeterminate EIN Presswire
Conavi Medical Announces New Grants of Stock Options
Oct. 19, 2026

Conavi Medical Announces New Grants of Stock Options

Indeterminate GlobeNewswire
Five Reputable Spa Manufacturers in China 2026: Advancing Wellness Equipment
Oct. 19, 2026

Five Reputable Spa Manufacturers in China 2026: Advancing Wellness Equipment

Indeterminate EIN Presswire
Vivos Therapeutics Closes Acquisition of Stake in SOD Sciences and 50% Interest in Pseudohypoxia Test, Opening a Potential Path to Access More Than 325,000 New Patients Through the AHA Channel
Oct. 19, 2026

Vivos Therapeutics Closes Acquisition of Stake in SOD Sciences and 50% Interest in Pseudohypoxia Test, Opening a Potential Path to Access More Than 325,000 New Patients Through the AHA Channel

Indeterminate GlobeNewswire
CytoDyn Appoints Robert E. Hoffman as Chief Executive Officer
Oct. 19, 2026

CytoDyn Appoints Robert E. Hoffman as Chief Executive Officer

Indeterminate GlobeNewswire
Clover Health Earns Top Honors in U.S. News & World Report's 2027 Medicare Advantage Ratings Across Three States
Oct. 19, 2026

Clover Health Earns Top Honors in U.S. News & World Report's 2027 Medicare Advantage Ratings Across Three States

Indeterminate GlobeNewswire
Structure Therapeutics Announces Multiple Upcoming Presentations at ObesityWeek® 2026
Oct. 19, 2026

Structure Therapeutics Announces Multiple Upcoming Presentations at ObesityWeek® 2026

Indeterminate GlobeNewswire
SI-BONE To Report Third Quarter 2026 Financial Results on November 2, 2026
Oct. 19, 2026

SI-BONE To Report Third Quarter 2026 Financial Results on November 2, 2026

Indeterminate GlobeNewswire
Pliant Therapeutics Announces Upcoming Presentation at European Society for Medical Oncology Congress 2026
Oct. 19, 2026

Pliant Therapeutics Announces Upcoming Presentation at European Society for Medical Oncology Congress 2026

Indeterminate GlobeNewswire
Fortrea Completes Acquisition of the Early Phase Services Division from Worldwide Clinical Trials
Oct. 19, 2026

Fortrea Completes Acquisition of the Early Phase Services Division from Worldwide Clinical Trials

Indeterminate GlobeNewswire
Mineralys Therapeutics Expands its Board of Directors with the Appointments of Kristine Peterson and Lonnel Coats
Oct. 19, 2026

Mineralys Therapeutics Expands its Board of Directors with the Appointments of Kristine Peterson and Lonnel Coats

Indeterminate GlobeNewswire
CRISPR Therapeutics Announces Chief Financial Officer Transition
Oct. 19, 2026

CRISPR Therapeutics Announces Chief Financial Officer Transition

Indeterminate GlobeNewswire
Integra Announces Completion of Refinancing Transactions
Oct. 19, 2026

Integra Announces Completion of Refinancing Transactions

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Healthy Living Europe

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.